Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

AASLD: Once-Daily HCV Protease Inhibitors Show Early Promise

Loading...

Sign in or sign up now!
355 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Nov 4, 2009

http://www.medpagetoday.com

BOSTON -- Two investigational drugs targeting the hepatitis C virus (HCV) protease enzyme helped patients clear the virus with once-daily dosing, in contrast with the three-times-per-day schedule needed for similar drugs in development.

Category:

News & Politics

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more